SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-023553
Filing Date
2011-04-22
Accepted
2011-04-22 12:44:13
Documents
15
Period of Report
2010-12-31
Filing Date Changed
2011-04-22

Document Format Files

Seq Description Document Type Size
1 v219311_20f.htm 20-F 2271459
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC spacer.gif GRAPHIC 43
4 GRAPHIC v219311_chrt-drug.jpg GRAPHIC 32492
5 GRAPHIC v219311_chrt-drug1.jpg GRAPHIC 38430
6 GRAPHIC v219311_chrt-flow.jpg GRAPHIC 17488
7 GRAPHIC v219311_chrt-flow1.jpg GRAPHIC 26419
8 GRAPHIC v219311_chrt-shaded.jpg GRAPHIC 77672
9 GRAPHIC v219311_kexing.jpg GRAPHIC 519
10 v219311_ex8-1.htm EX-8.1 5499
11 v219311_ex12-1.htm EX-12.1 14282
12 v219311_ex12-2.htm EX-12.2 14306
13 v219311_ex13-1.htm EX-13.1 6222
14 v219311_ex13-2.htm EX-13.2 6238
15 v219311_ex15-1.htm EX-15.1 3691
  Complete submission text file 0001144204-11-023553.txt   2590096
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Filer) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 0430
Type: 20-F | Act: 34 | File No.: 001-32371 | Film No.: 11775217
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1